Fig 1. Participants who were genotyped using OncoArray, who were whole exome sequenced using Roche SeqCap EZ Human Exome v3.0, and/or had information on methylation levels measured using Illumina Infinium MethylationEPIC BeadChip.

*All patients who were genotyped were part of Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES).